Author:
Humphrey Shannon,Femmer Priya,Beleznay Katie,Carruthers Jean D.A.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,General Medicine,Surgery
Reference5 articles.
1. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study;Ascher;J Eur Acad Dermatol Venereol,2014
2. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study;Rzany;Br J Dermatol,2014
3. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction;Jones;Dermatol Surg,2016
4. ATX-101 for reduction of submental fat: a phase III randomized controlled trial;Humphrey;J Am Acad Dermatol,2016
5. Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat;McDiarmid;Aesthet Plast Surg,2014
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献